• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用基于 MRI 的瘤内放射组学特征和瘤周水肿/肿瘤体积比区分脑脓肿和坏死性胶质母细胞瘤。

Distinguishing brain abscess from necrotic glioblastoma using MRI-based intranodular radiomic features and peritumoral edema/tumor volume ratio.

机构信息

Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022 Wuhan, Hubei, China.

出版信息

J Integr Neurosci. 2021 Sep 30;20(3):623-634. doi: 10.31083/j.jin2003066.

DOI:10.31083/j.jin2003066
PMID:34645095
Abstract

A correct preoperative diagnosis is essential for the treatment and prognosis of necrotic glioblastoma and brain abscess, but the differentiation between them remains challenging. We constructed a diagnostic prediction model with good performance and enhanced clinical applicability based on data from 86 patients with necrotic glioblastoma and 32 patients with brain abscess that were diagnosed between January 2012 and January 2020. The diagnostic values of three regions of interest based on contrast-enhanced T1 weighted images (including whole tumor, brain-tumor interface, and an amalgamation of both regions) were compared using Logistics Regression and Random Forest. Feature reduction based on the optimal regions of interest was performed using principal component analysis with varimax rotation. The performance of the classifiers was assessed by receiver operator curves. Finally, clinical predictors were utilized to detect the diagnostic power. The mean area under curve (AUC) values of the whole tumor model was significantly higher than other two models obtained from Brain-Tumor Interface (BTI) and combine regions both in training (AUC mean = 0.850) and test/validation set (AUC mean = 0.896) calculated by Logistics Regression and in the testing set (AUC mean = 0.876) calculated by Random Forest. Among these three diagnostic prediction models, the combined model provided superior discrimination performance and yielded an AUC of 0.993, 0.907, and 0.974 in training, testing, and combined datasets, respectively. Compared with the brain-tumor interface and the combined regions, features obtained from the whole tumor showed the best differential value. The radiomic features combined with the peritumoral edema/tumor volume ratio provided the prediction model with the greatest diagnostic performance.

摘要

正确的术前诊断对于治疗和预测坏死性脑胶质瘤和脑脓肿至关重要,但两者的鉴别仍然具有挑战性。我们基于 2012 年 1 月至 2020 年 1 月间诊断的 86 例坏死性脑胶质瘤和 32 例脑脓肿患者的数据,构建了一个具有良好性能和增强临床适用性的诊断预测模型。利用逻辑回归和随机森林比较了基于增强 T1 加权图像的三个感兴趣区(包括全肿瘤、肿瘤-脑界面和两者的融合区)的诊断价值。利用主成分分析和方差极大旋转对基于最优感兴趣区的特征进行降维。通过接受者操作特征曲线评估分类器的性能。最后,利用临床预测因子检测诊断能力。在训练和测试/验证集中,全肿瘤模型的平均曲线下面积(AUC)值均显著高于基于肿瘤-脑界面(BTI)和融合区的模型(AUC 均值分别为 0.850 和 0.896),在随机森林计算的测试集中 AUC 均值为 0.876。在这三个诊断预测模型中,联合模型提供了卓越的鉴别性能,在训练、测试和联合数据集的 AUC 分别为 0.993、0.907 和 0.974。与肿瘤-脑界面和融合区相比,全肿瘤区的特征显示出最佳的区分价值。肿瘤周围水肿/肿瘤体积比与放射组学特征相结合,为预测模型提供了最佳的诊断性能。

相似文献

1
Distinguishing brain abscess from necrotic glioblastoma using MRI-based intranodular radiomic features and peritumoral edema/tumor volume ratio.使用基于 MRI 的瘤内放射组学特征和瘤周水肿/肿瘤体积比区分脑脓肿和坏死性胶质母细胞瘤。
J Integr Neurosci. 2021 Sep 30;20(3):623-634. doi: 10.31083/j.jin2003066.
2
High-performance presurgical differentiation of glioblastoma and metastasis by means of multiparametric neurite orientation dispersion and density imaging (NODDI) radiomics.通过多参数神经丝取向分散和密度成像(NODDI)放射组学对胶质母细胞瘤和转移瘤进行高性能术前鉴别。
Eur Radiol. 2024 Oct;34(10):6616-6628. doi: 10.1007/s00330-024-10686-8. Epub 2024 Mar 15.
3
Radiomics in peritumoral non-enhancing regions: fractional anisotropy and cerebral blood volume improve prediction of local progression and overall survival in patients with glioblastoma.瘤周非增强区的放射组学:各向异性分数和脑血容量可提高胶质母细胞瘤患者局部进展和总生存期的预测能力。
Neuroradiology. 2019 Nov;61(11):1261-1272. doi: 10.1007/s00234-019-02255-4. Epub 2019 Jul 9.
4
Differentiation of supratentorial single brain metastasis and glioblastoma by using peri-enhancing oedema region-derived radiomic features and multiple classifiers.利用瘤周水肿区衍生的放射组学特征和多分类器对幕上单发脑转移瘤和胶质母细胞瘤进行鉴别。
Eur Radiol. 2020 May;30(5):3015-3022. doi: 10.1007/s00330-019-06460-w. Epub 2020 Jan 31.
5
Radiomics features to distinguish glioblastoma from primary central nervous system lymphoma on multi-parametric MRI.基于多参数MRI的区分胶质母细胞瘤与原发性中枢神经系统淋巴瘤的影像组学特征
Neuroradiology. 2018 Dec;60(12):1297-1305. doi: 10.1007/s00234-018-2091-4. Epub 2018 Sep 19.
6
Analysis of heterogeneity of peritumoral T2 hyperintensity in patients with pretreatment glioblastoma: Prognostic value of MRI-based radiomics.术前胶质母细胞瘤患者瘤周 T2 高信号异质性分析:基于 MRI 的放射组学的预后价值。
Eur J Radiol. 2019 Nov;120:108642. doi: 10.1016/j.ejrad.2019.108642. Epub 2019 Sep 14.
7
Robust performance of deep learning for distinguishing glioblastoma from single brain metastasis using radiomic features: model development and validation.深度学习利用放射组学特征区分胶质母细胞瘤与单发脑转移瘤的稳健性能:模型的建立与验证。
Sci Rep. 2020 Jul 21;10(1):12110. doi: 10.1038/s41598-020-68980-6.
8
Noninvasive O Methylguanine-DNA Methyltransferase Status Prediction in Glioblastoma Multiforme Cancer Using Magnetic Resonance Imaging Radiomics Features: Univariate and Multivariate Radiogenomics Analysis.使用磁共振成像放射组学特征无创性 O6-甲基鸟嘌呤-DNA 甲基转移酶状态预测多形性胶质母细胞瘤:单变量和多变量放射基因组学分析。
World Neurosurg. 2019 Dec;132:e140-e161. doi: 10.1016/j.wneu.2019.08.232. Epub 2019 Sep 7.
9
Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients.将弥散加权和灌注加权 MRI 纳入放射组学模型可提高胶质母细胞瘤患者假性进展的诊断性能。
Neuro Oncol. 2019 Feb 19;21(3):404-414. doi: 10.1093/neuonc/noy133.
10
Susceptibility-weighted imaging provides complementary value to diffusion-weighted imaging in the differentiation between pyogenic brain abscesses, necrotic glioblastomas, and necrotic metastatic brain tumors.磁敏感加权成像在鉴别化脓性脑脓肿、坏死性胶质母细胞瘤和坏死性转移性脑肿瘤方面提供了与弥散加权成像互补的价值。
Eur J Radiol. 2019 Aug;117:56-61. doi: 10.1016/j.ejrad.2019.05.021. Epub 2019 May 30.

引用本文的文献

1
FLAIR-based radiomics signature from brain-tumor interface for early prediction of response to EGFR-TKI therapy in NSCLC patients with brain metastasis.基于液体衰减反转恢复序列(FLAIR)的脑肿瘤界面放射组学特征,用于早期预测非小细胞肺癌脑转移患者对表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKI)治疗的反应
Front Cell Dev Biol. 2025 May 14;13:1525989. doi: 10.3389/fcell.2025.1525989. eCollection 2025.
2
Clinicodemographic and Radiological Features of Infective Ring-Enhancing Brain Lesions: A 4-Year Retrospective Study at a Tertiary Referral Center.感染性脑环形强化病变的临床人口统计学和影像学特征:在一家三级转诊中心进行的为期4年的回顾性研究。
Open Forum Infect Dis. 2025 Feb 26;12(3):ofaf095. doi: 10.1093/ofid/ofaf095. eCollection 2025 Mar.
3
Correlation of Edema/Tumor Index With Histopathological Outcomes According to the WHO Classification of Cranial Tumors.
根据世界卫生组织(WHO)颅骨肿瘤分类,水肿/肿瘤指数与组织病理学结果的相关性
Cureus. 2024 Nov 3;16(11):e72942. doi: 10.7759/cureus.72942. eCollection 2024 Nov.
4
Radiomics based on brain-to-tumor interface enables prediction of metastatic tumor type of brain metastasis: a proof-of-concept study.基于脑-肿瘤界面的影像组学能够预测脑转移瘤的转移瘤类型:一项概念验证研究。
Radiol Med. 2025 Feb;130(2):190-201. doi: 10.1007/s11547-024-01934-4. Epub 2024 Nov 22.
5
Radiomics and Machine Learning in Brain Tumors and Their Habitat: A Systematic Review.脑肿瘤及其瘤周组织的影像组学与机器学习:一项系统综述
Cancers (Basel). 2023 Jul 28;15(15):3845. doi: 10.3390/cancers15153845.
6
Classification of brain lesions using a machine learning approach with cross-sectional ADC value dynamics.基于横断面 ADC 值动态的机器学习方法对脑病变进行分类。
Sci Rep. 2023 Jul 15;13(1):11459. doi: 10.1038/s41598-023-38542-7.
7
Case report: Cryptogenic giant brain abscess caused by mimicking stroke and tumor in a patient with impaired immunity.病例报告:免疫功能受损患者中由酷似中风和肿瘤引起的隐源性巨大脑脓肿。
Front Neurol. 2022 Sep 23;13:1007435. doi: 10.3389/fneur.2022.1007435. eCollection 2022.
8
A Systematic Review of the Current Status and Quality of Radiomics for Glioma Differential Diagnosis.胶质瘤鉴别诊断中影像组学现状与质量的系统评价
Cancers (Basel). 2022 May 31;14(11):2731. doi: 10.3390/cancers14112731.